Recent advances in pulmonary arterial hypertension

Pulmonary arterial hypertension (PAH) is a rare disorder with a high mortality rate. Treatment options have improved in the last 20 years, but patients still die prematurely of right heart failure. Though rare, it is heterogeneous at the genetic and molecular level, and understanding and exploiting...

Descripción completa

Detalles Bibliográficos
Autores principales: Wilkins, Martin R., Aman, Jurjan, Harbaum, Lars, Ulrich, Anna, Wharton, John, Rhodes, Christopher J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058465/
https://www.ncbi.nlm.nih.gov/pubmed/30079232
http://dx.doi.org/10.12688/f1000research.14984.1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058465/
https://www.ncbi.nlm.nih.gov/pubmed/30079232
http://dx.doi.org/10.12688/f1000research.14984.1

Ejemplares similares